BHC — Bausch Health Companies Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 885590 ·
Last close
$6.89
Market Cap
$2.57B
52W High
$6.91
52W Low
$4.33
ADV30
3,659,541
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 2,524,000,000 | 1,786,000,000 | 521,000,000 | -1,423,000,000 | 24,498,000,000 | 1,299,000,000 | 25,580,000,000 |
| Dec 2025 | 2,796,000,000 | 1,998,000,000 | 829,000,000 | -112,000,000 | 26,366,000,000 | 1,309,000,000 | 25,989,000,000 |
| Sep 2025 | 2,681,000,000 | 1,931,000,000 | 636,000,000 | 179,000,000 | 26,824,000,000 | 1,308,000,000 | 26,468,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,419,000,000
Investing CF
$-604,000,000
Financing CF
$-696,000,000
CapEx
$-430,000,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-3.24
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-11,090,000,000
Inventory
$1,601,000,000
Receivables
$2,191,000,000
ST Investments
—
EBIT TTM
$736,000,000
Pretax Income TTM
$-940,000,000
Interest Exp TTM
$1,676,000,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,853,000,192
EBITDA
$3,854,000,128
Free Cash Flow
$1,123,500,032
Enterprise Value
$22,725,058,560
Total Cash
$1,299,000,064
Total Debt
$20,795,000,832
Shares Out
373,475,644
Trailing EPS
$-2.94
Book Value
$-5.51
ROE
—
ROA
5.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,266,000,000 | 2,185,000,000 | 157,000,000 | 26,366,000,000 | 25,989,000,000 | — | 1,400,000,000 |
| Dec 2024 | 9,625,000,000 | 1,854,000,000 | -46,000,000 | 26,523,000,000 | 26,845,000,000 | — | 1,597,000,000 |
| Dec 2023 | 8,757,000,000 | 1,600,000,000 | -592,000,000 | 27,350,000,000 | 27,432,000,000 | — | 1,032,000,000 |
| Dec 2022 | 8,124,000,000 | 1,391,000,000 | -225,000,000 | 25,686,000,000 | 25,426,000,000 | — | -728,000,000 |
TTM Snapshot
Revenues TTM
$8,905,000,000
NetIncome TTM
$124,000,000
OpCashFlow TTM
$0
Assets (Latest)
$26,523,000,000
Forward EPS
$3.88
Max Pain — expiry 2026-08-21
max pain strike: $5.00 · spot: $6.89 · call oi: 15,253 · put oi: 1,679
Expected Move to 2026-08-21:
±$0.95
(13.79%) —
implied range
$5.94 –
$7.84
· ATM straddle on $7.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IMNM | Immunome Inc. | $2.58B | $22.76 | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $2.59B | $44.63 | — |
| TRVI | Trevi Therapeutics, Inc. | $2.59B | $18.25 | — |
| ATAI | AtaiBeckley Inc. | $2.66B | $7.18 | — |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.45B | $24.91 | — |
News headlines (Yahoo Finance, 1h cache)
Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook
2026-07-31 04:03 · Yahoo
Sector Update: Healthcare Stocks Decline Late Afternoon
2026-07-30 19:46 · Yahoo
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
2026-07-30 16:33 · Yahoo
Bausch Health Companies Inc. Q2 2026 Earnings Call Summary
2026-07-30 12:30 · Yahoo
Bausch Health Cos Q2 Earnings Call Highlights
2026-07-30 01:04 · Yahoo
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
2026-07-30 00:35 · Yahoo
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
2026-07-29 23:30 · Yahoo
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
2026-07-29 20:05 · Yahoo
(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis
2026-07-28 12:00 · Yahoo
Bausch Health’s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary
2026-07-12 17:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.